Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show

Gilead Sciences to Present at the Jefferies 2019 Global Healthcare Conference on Wednesday, June 5


Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Daniel O'Day, Gilead's Chairman and Chief Executive Officer, will participate in a fireside chat at the Jefferies 2019 Global Healthcare Conference in New York on Wednesday, June 5 at 11:30 a.m. Eastern Time.

The audio portion of the fireside chat will be accessible live through the company's Investors page at http://investors.gilead.com/. Please connect to the company's website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be required to listen to the webcast. The replay will be available for 14 days following the presentation.

About Gilead Sciences

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company's website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.


These press releases may also interest you

at 12:00
Thought leaders from Arizona-based Maricopa Integrated Health System and nThrive will share how a holistic approach to denials management can help providers thrive in the new clinically-driven revenue cycle management environment. Kathie Kirkland,...

at 11:58
Synergistic Therapeutics LLC has recently announced issuance of a U.S. Patent for a topical solution that slows hair loss and generates new hair growth in men and women(1,2). Synergistic Therapeutics LLC, a Florida-based company formed in 2015,...

at 11:57
Centene Corporation ("Centene") and WellCare Health Plans, Inc. ("WellCare") today announced that the stockholders of both companies approved all proposals regarding Centene's pending acquisition of WellCare pursuant to the definitive merger...

at 11:45
The "Market Spotlight: Eating Disorders" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the Eating Disorders market, comprising key marketed and pipeline drugs, clinical trials, upcoming events, patent...

at 11:40
John Weiss & Son, the leading manufacturer and distributor of gold-standard ophthalmic micro-surgical instruments and procedures, is pleased to announce the creation of a brand new product information section on its website, which is now live...

at 11:31
The Honourable Eileen E. Gillese, Commissioner of the Public Inquiry into the Safety and Security of Residents in the Long-Term Care Homes System has announced that she will release her final Report, complete with Recommendations, at noon on...



News published on 21 may 2019 at 16:05 and distributed by: